Skip to main content
ADIL
NASDAQ Life Sciences

Adial Pharmaceuticals Announces Azora Therapeutics Acquisition, Up To $64M Financing

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$2.13
Mkt Cap
$4.566M
52W Low
$1.31
52W High
$18.9
52W Position info
63% above low
Off High info
89% below high
Rel. Volume
Market data snapshot near publication time

ADIL sits 63% above its 52-week low of $1.31.

Summary

Adial Pharmaceuticals announced the acquisition of Azora Therapeutics, alongside a financing deal for up to $64 million. This substantial financing, which is over 14 times the company's current market capitalization, addresses the going concern warning reiterated in the May 8th 10-Q, which stated cash was only sufficient into the second half of 2026. While providing critical capital, the financing implies extreme dilution for existing shareholders. The acquisition of Azora Therapeutics marks a significant strategic expansion for the company.

At the time of this announcement, ADIL was trading at $2.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.6M. The 52-week trading range was $1.31 to $18.90. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ADIL - Latest Insights

ADIL
Nov 12, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.86
Real-time Price: $4.86 info
Change: $0 (0%) info
Market Cap: $13.261M info
ADIL
Nov 12, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.86
Real-time Price: $4.86 info
Change: $0 (0%) info
Market Cap: $13.261M info
ADIL
Nov 09, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.86
Real-time Price: $4.86 info
Change: $0 (0%) info
Market Cap: $13.261M info
ADIL
Oct 28, 2026, 5:56 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.08
Real-time Price: $4.86 info
Change: -$0.220 (-4%) info
Market Cap: $13.261M info
ADIL
Oct 28, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.86
Real-time Price: $4.86 info
Change: -$0.0036 (-0.07%) info
Market Cap: $13.261M info